These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9377626)

  • 1. Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing.
    Wellman G; Sherrin T
    Clin Ther; 1997; 19(4):837-46. PubMed ID: 9377626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease.
    Kitzman DW; Wesley DJ
    Am Heart J; 2000 Jun; 139(6):1077-80. PubMed ID: 10827390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography.
    Grayburn P
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I12-8. PubMed ID: 9383597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.
    Quay SC; Eisenfeld AJ
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I19-26. PubMed ID: 9383598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The improvement of echocardiographic assessment of the left ventricle by the use of perflenapent and harmonic imaging].
    Olszewski R; Marciniak W; Nowicki A; Gil M; Etienne J; Karłowicz P; Adamus J
    Pol Merkur Lekarski; 1998 Sep; 5(27):132-4. PubMed ID: 10101477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications.
    Shaw LJ
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I39-48. PubMed ID: 9383601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing.
    Thanigaraj S; Nease RF; Schechtman KB; Wade RL; Loslo S; Pérez JE
    Am J Cardiol; 2001 Jun; 87(12):1430-2. PubMed ID: 11397374
    [No Abstract]   [Full Text] [Related]  

  • 8. Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group.
    Robbin ML; Eisenfeld AJ
    Radiology; 1998 Jun; 207(3):717-22. PubMed ID: 9609895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit.
    Yong Y; Wu D; Fernandes V; Kopelen HA; Shimoni S; Nagueh SF; Callahan JD; Bruns DE; Shaw LJ; Quinones MA; Zoghbi WA
    Am J Cardiol; 2002 Mar; 89(6):711-8. PubMed ID: 11897214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and time-efficiency of a "sonographer-driven" contrast echocardiography protocol in a high-volume echocardiography laboratory.
    Castello R; Bella JN; Rovner A; Swan J; Smith J; Shaw L
    Am Heart J; 2003 Mar; 145(3):535-41. PubMed ID: 12660679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.
    Sharples L; Hughes V; Crean A; Dyer M; Buxton M; Goldsmith K; Stone D
    Health Technol Assess; 2007 Dec; 11(49):iii-iv, ix-115. PubMed ID: 18021576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an intravenous contrast agent (Optison) to enhance echocardiography: efficacy and cost implications. Optison Multicenter Study Group.
    Shaw LJ; Gillam L; Feinstein S; Dent J; Plotnick G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP169-76. PubMed ID: 10185992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-efficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram.
    Wyrick JJ; Kalvaitis S; McConnell KJ; Rinkevich D; Kaul S; Wei K
    Am J Cardiol; 2008 Sep; 102(6):649-52. PubMed ID: 18773981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings.
    Shaw LJ; Dittrich HC
    Acad Radiol; 1998 Apr; 5 Suppl 1():S250-1; discussion S252-3. PubMed ID: 9561093
    [No Abstract]   [Full Text] [Related]  

  • 15. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study.
    Lopez-Ben R; Robbin ML; Weber TM; Smith JK; Needleman L; Berland LL
    J Ultrasound Med; 1999 Feb; 18(2):109-16. PubMed ID: 10206803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefits of using second generation ultrasound contrast agents in stress echocardiography.
    Jung PH; Angermann CE
    Echocardiography; 2003 Aug; 20 Suppl 1():S11-8. PubMed ID: 23573621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction.
    Lehman EP; Cowper PA; Randolph TC; Kosinski AS; Lopes RD; Douglas PS
    Am J Cardiol; 2018 Jul; 122(1):121-128. PubMed ID: 29753394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimbursement for new diagnostic imaging technologies: process, progress, and problems.
    Pearlman AS
    Am J Cardiol; 2002 Nov; 90(10A):17J-20J. PubMed ID: 12450586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.